Literature DB >> 17074870

Potential population impact of the UK government strategy for reducing the burden of coronary heart disease in England: comparing primary and secondary prevention strategies.

I Gemmell1, R F Heller, K Payne, R Edwards, M Roland, P Durrington.   

Abstract

OBJECTIVE: To use population impact measures to help prioritise the National Service Framework (NSF) strategies recommended by the UK government for reducing the population burden of coronary heart disease (CHD).
DESIGN: Modelling study.
SETTING: Primary care. DATA SOURCES: Published data on incidence, baseline risk and prevalence of risk factors for CHD and the proportion treated, eligible for treatment, and adhering to the different interventions. Data from meta-analyses and systematic reviews for relative risk and relative risk reduction associated with different risk factors and interventions. MAIN OUTCOME MEASURES: Population impact measures for the decline in the prevalence of a risk factor and the increased uptake of interventions expressed as number of CHD events prevented in the population.
RESULTS: If lifestyle targets for primary prevention are met, 73 522 (95% CI 54,117 to 95,826) CHD events would be prevented per year, with the greatest gain coming from reduced cholesterol and blood pressure levels. In those at high risk of developing CHD, achieving target levels for lifestyle interventions would prevent 4410 (95% CI 1993 to 8014) CHD events and for pharmacological treatments 2008 (95% CI 790 to 3627) CHD events. For patients with established CHD, achieving NSF targets will result in the prevention of 3067 (95% CI 1572 to 5878) CHD events through improved drug treatment and 1103 (95% CI 179 to 2097) events through lifestyle interventions.
CONCLUSION: Current strategies focus largely on secondary prevention, but many more cardiovascular events would be prevented by meeting the government's public health and primary prevention targets than targeting people at high risk or those with established heart disease.

Entities:  

Mesh:

Year:  2006        PMID: 17074870      PMCID: PMC2565818          DOI: 10.1136/qshc.2005.017061

Source DB:  PubMed          Journal:  Qual Saf Health Care        ISSN: 1475-3898


  31 in total

1.  Effectiveness of individual lifestyle interventions in reducing cardiovascular disease and risk factors.

Authors:  E Ketola; R Sipilä; M Mäkelä
Journal:  Ann Med       Date:  2000-05       Impact factor: 4.709

Review 2.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.

Authors:  M R Law; N J Wald; A R Rudnicka
Journal:  BMJ       Date:  2003-06-28

3.  Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland.

Authors:  S Capewell; B M Livingston; K MacIntyre; J W Chalmers; J Boyd; A Finlayson; A Redpath; J P Pell; C J Evans; J J McMurray
Journal:  Eur Heart J       Date:  2000-11       Impact factor: 29.983

4.  Population impact of stricter adherence to recommendations for pharmacological and lifestyle interventions over one year in patients with coronary heart disease.

Authors:  I Gemmell; R F Heller; P McElduff; K Payne; G Butler; R Edwards; M Roland; P Durrington
Journal:  J Epidemiol Community Health       Date:  2005-12       Impact factor: 3.710

5.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

6.  High lipid levels and coronary disease in women in Göteborg--outcome and secular trends: a prospective 19 year follow-up in the BEDA*study.

Authors:  Saga Johansson; Lars Wilhelmsen; Georg Lappas; Annika Rosengren
Journal:  Eur Heart J       Date:  2003-04       Impact factor: 29.983

7.  N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials.

Authors:  Heiner C Bucher; Peter Hengstler; Christian Schindler; Gabriela Meier
Journal:  Am J Med       Date:  2002-03       Impact factor: 4.965

8.  Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels.

Authors:  J A Critchley; S Capewell
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

9.  Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

Authors:  Bruce M Psaty; Thomas Lumley; Curt D Furberg; Gina Schellenbaum; Marco Pahor; Michael H Alderman; Noel S Weiss
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

10.  Implementing guidelines in primary care: can population impact measures help?

Authors:  Richard F Heller; Richard Edwards; Patrick McElduff
Journal:  BMC Public Health       Date:  2003-01-23       Impact factor: 3.295

View more
  5 in total

1.  Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study.

Authors:  Parinya Chamnan; Rebecca K Simmons; Kay-Tee Khaw; Nicholas J Wareham; Simon J Griffin
Journal:  BMJ       Date:  2010-04-23

2.  Appropriateness of cardiovascular care in elderly adult cancer survivors.

Authors:  Winson Y Cheung; Raisa Levin; Soko Setoguchi
Journal:  Med Oncol       Date:  2013-04-06       Impact factor: 3.064

3.  Predictors of health-related quality of life in patients at risk for cardiovascular disease in European primary care.

Authors:  Sabine Ludt; Michel Wensing; Joachim Szecsenyi; Jan van Lieshout; Justine Rochon; Tobias Freund; Stephen M Campbell; Dominik Ose
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

4.  Self reported receipt of care consistent with 32 quality indicators: national population survey of adults aged 50 or more in England.

Authors:  Nicholas Steel; Max Bachmann; Susan Maisey; Paul Shekelle; Elizabeth Breeze; Michael Marmot; David Melzer
Journal:  BMJ       Date:  2008-08-13

5.  Hypercholesterolaemia - practical information for non-specialists.

Authors:  Handrean Soran; Safwaan Adam; Jamal B Mohammad; Jan H Ho; Jonathan D Schofield; See Kwok; Tarza Siahmansur; Yifen Liu; Akheel A Syed; Shaishav S Dhage; Claudia Stefanutti; Rachelle Donn; Rayaz A Malik; Maciej Banach; Paul N Durrington
Journal:  Arch Med Sci       Date:  2017-12-19       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.